Health Canada inspection
Amphastar Pharmaceuticals, Inc.: Health Canada inspection of May 17, 2023
Health Canada · GMP · rating C
Key facts
| Establishment | Amphastar Pharmaceuticals, Inc. |
|---|---|
| City | Scarborough |
| Province | Ontario |
| Country | Canada |
| Program | GMP |
| Start date | May 17, 2023 |
| End date | May 17, 2023 |
| Rating | C |
| Rating description | Compliant |
| Licence number | 101197 |
At a glance
- 1–9 Observations cited
- 1–9 Inspections of this establishment
- Yes Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.